ReviewCancer pathogenesis and therapy2024

Impact of PD-1/PD-L1 inhibitors on survival in stage III non-small-cell lung cancer: A systematic review.

Petros Roussos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.